General Anesthesia Drugs MarketGeneral Anesthesia Drugs Market By Drug (Sevoflurane, Dexmedetomidine, Propofol, Remifentanil, and Others), By Route of Administration (Intravenous and Inhaled), By Application (Heart Surgeries, Knee & Hip Replacements, General Surgery, Cancer, and Others), By End-user (Hospitals, Ambulatory Surgical Centers, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Published date: March 2025
Report ID: 144042
Number of Pages: 397
Format:

Fact Checked

Cite this Research

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key General Anesthesia Drugs Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of General Anesthesia Drugs Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global General Anesthesia Drugs Market Analysis and Forecast, By Segment, 2020-2034
  - 3.1. Key Findings
  - 3.2. Global General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
  - 3.3. Global General Anesthesia Drugs Market Attractiveness Analysis, By Drug
    
    3.3.1. Propofol
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Sevoflurane
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
    
    3.3.3. Dexmedetomidine
    
    3.3.3.1. Insights
    
    3.3.3.2. Key Takeaways
    
    3.3.4. Remifentanil
    
    3.3.4.1. Insights
    
    3.3.4.2. Key Takeaways
    
    3.3.5. Others
    
    3.3.5.1. Insights
    
    3.3.5.2. Key Takeaways
  - 3.4. Global General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 3.5. Global General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
    
    3.5.1. Intravenous
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Inhaled
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
  - 3.6. Global General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 3.7. Global General Anesthesia Drugs Market Attractiveness Analysis, By Application
    
    3.7.1. Heart Surgeries
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Knee & Hip Replacements
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. General Surgery
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
    
    3.7.4. Cancer
    
    3.7.4.1. Insights
    
    3.7.4.2. Key Takeaways
    
    3.7.5. Others
    
    3.7.5.1. Insights
    
    3.7.5.2. Key Takeaways
  - 3.8. Global General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 3.9. Global General Anesthesia Drugs Market Attractiveness Analysis, By End-user
    
    3.9.1. Hospitals
    
    3.9.1.1. Insights
    
    3.9.1.2. Key Takeaways
    
    3.9.2. Ambulatory Surgical Centers
    
    3.9.2.1. Insights
    
    3.9.2.2. Key Takeaways
    
    3.9.3. Others
    
    3.9.3.1. Insights
    
    3.9.3.2. Key Takeaways
- 4. Global General Anesthesia Drugs Market Analysis and Forecast, By Region, 2020-2034
  - 4.1. Key Findings
  - 4.2. Global General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global General Anesthesia Drugs Market Attractiveness Analysis, By Region
- 5. North America General Anesthesia Drugs Market Analysis and Forecast, 2020-2034
  - 5.1. Key Findings
  - 5.2. North America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
  - 5.3. North America General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - 5.4. North America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 5.5. North America General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - 5.6. North America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 5.7. North America General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - 5.8. North America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 5.9. North America General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - 5.10. North America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 5.11. North America General Anesthesia Drugs Market Attractiveness Analysis, By Country
    
    5.11.1. The US
    
    5.11.2. Canada
- 6. Europe General Anesthesia Drugs Market Analysis and Forecast, 2020-2034
  - 6.1. Key Findings
  - 6.2. Europe General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
  - 6.3. Europe General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - 6.4. Europe General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 6.5. Europe General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - 6.6. Europe General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 6.7. Europe General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - 6.8. Europe General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 6.9. Europe General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - 6.10. Europe General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 6.11. Europe General Anesthesia Drugs Market Attractiveness Analysis, By Country
    
    6.11.1. Germany
    
    6.11.2. The UK
    
    6.11.3. France
    
    6.11.4. Spain
    
    6.11.5. Italy
    
    6.11.6. Russia
    
    6.11.7. Netherland
    
    6.11.8. Rest of Europe
- 7. Asia Pacific General Anesthesia Drugs Market Analysis and Forecast, 2020-2034
  - 7.1. Key Findings
  - 7.2. Asia Pacific General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
  - 7.3. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - 7.4. Asia Pacific General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 7.5. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - 7.6. Asia Pacific General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 7.7. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - 7.8. Asia Pacific General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 7.9. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - 7.10. Asia Pacific General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 7.11. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By Country
    
    7.11.1. China
    
    7.11.2. Japan
    
    7.11.3. South Korea
    
    7.11.4. India
    
    7.11.5. Australia
    
    7.11.6. New Zealand
    
    7.11.7. Singapore
    
    7.11.8. Thailand
    
    7.11.9. Vietnam
    
    7.11.10. Rest of Asia Pacific
- 8. Latin America General Anesthesia Drugs Market Analysis and Forecast, 2020-2034
  - 8.1. Key Findings
  - 8.2. Latin America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
  - 8.3. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - 8.4. Latin America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 8.5. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - 8.6. Latin America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 8.7. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - 8.8. Latin America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 8.9. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - 8.10. Latin America General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 8.11. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By Country
    
    8.11.1. Brazil
    
    8.11.2. Mexico
    
    8.11.3. Rest of Latin America
- 9. Middle East & Africa General Anesthesia Drugs Market Analysis and Forecast, 2020-2034
  - 9.1. Key Findings
  - 9.2. Middle East & Africa General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug, 2020-2034
  - 9.3. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - 9.4. Middle East & Africa General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 9.5. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - 9.6. Middle East & Africa General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 9.7. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - 9.8. Middle East & Africa General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 9.9. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - 9.10. Middle East & Africa General Anesthesia Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 9.11. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By Country
    
    9.11.1. South Africa
    
    9.11.2. Saudi Arabia
    
    9.11.3. UAE
    
    9.11.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Pfizer
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Hikama Pharmaceuticals plc
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Eugia Steriles
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Baxter International
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. B. Braun Melsungen AG
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. AstraZeneca
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Amneal Pharmaceuticals
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Abbott Laboratories
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 2. Global General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 3. Global General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 4. Global General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 5. Global General Anesthesia Drugs Market Value (US$ Mn), By Region, 2020-2034
  - Table 6. North America General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 7. North America General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 8. North America General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 9. North America General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 10. North America General Anesthesia Drugs Market Value (US$ Mn), By Country, 2020-2034
  - Table 11. The US General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 12. The US General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 13. The US General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 14. The US General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 15. Canada General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 16. Canada General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 17. Canada General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 18. Canada General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 19. Europe General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 20. Europe General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 21. Europe General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 22. Europe General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 23. Europe General Anesthesia Drugs Market Value (US$ Mn), By Country, 2020-2034
  - Table 24. Germany General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 25. Germany General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 26. Germany General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 27. Germany General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 28. The UK General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 29. The UK General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 30. The UK General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 31. The UK General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 32. France General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 33. France General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 34. France General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 35. France General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 36. Spain General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 37. Spain General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 38. Spain General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 39. Spain General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 40. Italy General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 41. Italy General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 42. Italy General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 43. Italy General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 44. Russia General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 45. Russia General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 46. Russia General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 47. Russia General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 48. Netherland General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 49. Netherland General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 50. Netherland General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 51. Netherland General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 52. Rest of Europe General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 53. Rest of Europe General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 54. Rest of Europe General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 55. Rest of Europe General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 56. Asia Pacific General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 57. Asia Pacific General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 58. Asia Pacific General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 59. Asia Pacific General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 60. Asia Pacific General Anesthesia Drugs Market Value (US$ Mn), By Country, 2020-2034
  - Table 61. China General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 62. China General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 63. China General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 64. China General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 65. India General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 66. India General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 67. India General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 68. India General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 69. Japan General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 70. Japan General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 71. Japan General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 72. Japan General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 73. South Korea General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 74. South Korea General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 75. South Korea General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 76. South Korea General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 77. Australia General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 78. Australia General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 79. Australia General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 80. Australia General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 81. New Zealand General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 82. New Zealand General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 83. New Zealand General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 84. New Zealand General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 85. Singapore General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 86. Singapore General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 87. Singapore General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 88. Singapore General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 89. Thailand General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 90. Thailand General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 91. Thailand General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 92. Thailand General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 93. Vietnam General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 94. Vietnam General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 95. Vietnam General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 96. Vietnam General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 97. Rest of Asia Pacific General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 98. Rest of Asia Pacific General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 99. Rest of Asia Pacific General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 100. Rest of Asia Pacific General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 101. Latin America General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 102. Latin America General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 103. Latin America General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 104. Latin America General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 105. Latin America General Anesthesia Drugs Market Value (US$ Mn), By Country, 2020-2034
  - Table 106. Brazil General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 107. Brazil General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 108. Brazil General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 109. Brazil General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 110. Mexico General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 111. Mexico General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 112. Mexico General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 113. Mexico General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 114. Rest of Latin America General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 115. Rest of Latin America General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 116. Rest of Latin America General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 117. Rest of Latin America General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 118. Middle East & Africa General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 119. Middle East & Africa General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 120. Middle East & Africa General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 121. Middle East & Africa General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 122. Middle East & Africa General Anesthesia Drugs Market Value (US$ Mn), By Country, 2020-2034
  - Table 123. South Africa General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 124. South Africa General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 125. South Africa General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 126. South Africa General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 127. Saudi Arabia General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 128. Saudi Arabia General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 129. Saudi Arabia General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 130. Saudi Arabia General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 131. UAE General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 132. UAE General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 133. UAE General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 134. UAE General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
  - Table 135. Rest of Middle East & Africa General Anesthesia Drugs Market Value (US$ Mn), By Drug, 2020-2034
  - Table 136. Rest of Middle East & Africa General Anesthesia Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 137. Rest of Middle East & Africa General Anesthesia Drugs Market Value (US$ Mn), By Application, 2020-2034
  - Table 138. Rest of Middle East & Africa General Anesthesia Drugs Market Value (US$ Mn), By End-user, 2020-2034
- List of Figures
  - Figure 1. Global General Anesthesia Drugs Market Snapshot: Market Value (US$ Mn), 2020-2034
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in General Anesthesia Drugs Market
  - Figure 5. Global General Anesthesia Drugs Market Analysis, By Drug, 2020, 2024 and 2034
  - Figure 6. Global General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - Figure 7. Global General Anesthesia Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 8. Global General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - Figure 9. Global General Anesthesia Drugs Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 10. Global General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - Figure 11. Global General Anesthesia Drugs Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 12. Global General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - Figure 13. Global General Anesthesia Drugs Market Analysis, By Region, 2020, 2024 and 2034
  - Figure 14. Global General Anesthesia Drugs Market Attractiveness Analysis, By Region
  - Figure 15. North America General Anesthesia Drugs Market Analysis, By Drug, 2020, 2024 and 2034
  - Figure 16. North America General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - Figure 17. North America General Anesthesia Drugs Market (US$ Mn), by Propofol, 2020-2034
  - Figure 18. North America General Anesthesia Drugs Market (US$ Mn), by Sevoflurane, 2020-2034
  - Figure 19. North America General Anesthesia Drugs Market (US$ Mn), by Dexmedetomidine, 2020-2034
  - Figure 20. North America General Anesthesia Drugs Market (US$ Mn), by Remifentanil, 2020-2034
  - Figure 21. North America General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 22. North America General Anesthesia Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 23. North America General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - Figure 24. North America General Anesthesia Drugs Market (US$ Mn), by Intravenous, 2020-2034
  - Figure 25. North America General Anesthesia Drugs Market (US$ Mn), by Inhaled, 2020-2034
  - Figure 26. North America General Anesthesia Drugs Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 27. North America General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - Figure 28. North America General Anesthesia Drugs Market (US$ Mn), by Heart Surgeries, 2020-2034
  - Figure 29. North America General Anesthesia Drugs Market (US$ Mn), by Knee & Hip Replacements, 2020-2034
  - Figure 30. North America General Anesthesia Drugs Market (US$ Mn), by General Surgery, 2020-2034
  - Figure 31. North America General Anesthesia Drugs Market (US$ Mn), by Cancer, 2020-2034
  - Figure 32. North America General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 33. North America General Anesthesia Drugs Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 34. North America General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - Figure 35. North America General Anesthesia Drugs Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 36. North America General Anesthesia Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2020-2034
  - Figure 37. North America General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 38. North America General Anesthesia Drugs Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 39. North America General Anesthesia Drugs Market Attractiveness Analysis, By Country
  - Figure 40. Europe General Anesthesia Drugs Market Analysis, By Drug, 2020, 2024 and 2034
  - Figure 41. Europe General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - Figure 42. Europe General Anesthesia Drugs Market (US$ Mn), by Propofol, 2020-2034
  - Figure 43. Europe General Anesthesia Drugs Market (US$ Mn), by Sevoflurane, 2020-2034
  - Figure 44. Europe General Anesthesia Drugs Market (US$ Mn), by Dexmedetomidine, 2020-2034
  - Figure 45. Europe General Anesthesia Drugs Market (US$ Mn), by Remifentanil, 2020-2034
  - Figure 46. Europe General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 47. Europe General Anesthesia Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 48. Europe General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - Figure 49. Europe General Anesthesia Drugs Market (US$ Mn), by Intravenous, 2020-2034
  - Figure 50. Europe General Anesthesia Drugs Market (US$ Mn), by Inhaled, 2020-2034
  - Figure 51. Europe General Anesthesia Drugs Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 52. Europe General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - Figure 53. Europe General Anesthesia Drugs Market (US$ Mn), by Heart Surgeries, 2020-2034
  - Figure 54. Europe General Anesthesia Drugs Market (US$ Mn), by Knee & Hip Replacements, 2020-2034
  - Figure 55. Europe General Anesthesia Drugs Market (US$ Mn), by General Surgery, 2020-2034
  - Figure 56. Europe General Anesthesia Drugs Market (US$ Mn), by Cancer, 2020-2034
  - Figure 57. Europe General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 58. Europe General Anesthesia Drugs Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 59. Europe General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - Figure 60. Europe General Anesthesia Drugs Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 61. Europe General Anesthesia Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2020-2034
  - Figure 62. Europe General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 63. Europe General Anesthesia Drugs Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 64. Europe General Anesthesia Drugs Market Attractiveness Analysis, By Country
  - Figure 65. Asia Pacific General Anesthesia Drugs Market Analysis, By Drug, 2020, 2024 and 2034
  - Figure 66. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - Figure 67. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Propofol, 2020-2034
  - Figure 68. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Sevoflurane, 2020-2034
  - Figure 69. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Dexmedetomidine, 2020-2034
  - Figure 70. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Remifentanil, 2020-2034
  - Figure 71. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 72. Asia Pacific General Anesthesia Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 73. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - Figure 74. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Intravenous, 2020-2034
  - Figure 75. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Inhaled, 2020-2034
  - Figure 76. Asia Pacific General Anesthesia Drugs Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 77. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - Figure 78. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Heart Surgeries, 2020-2034
  - Figure 79. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Knee & Hip Replacements, 2020-2034
  - Figure 80. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by General Surgery, 2020-2034
  - Figure 81. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Cancer, 2020-2034
  - Figure 82. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 83. Asia Pacific General Anesthesia Drugs Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 84. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - Figure 85. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 86. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2020-2034
  - Figure 87. Asia Pacific General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 88. Asia Pacific General Anesthesia Drugs Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 89. Asia Pacific General Anesthesia Drugs Market Attractiveness Analysis, By Country
  - Figure 90. Latin America General Anesthesia Drugs Market Analysis, By Drug, 2020, 2024 and 2034
  - Figure 91. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - Figure 92. Latin America General Anesthesia Drugs Market (US$ Mn), by Propofol, 2020-2034
  - Figure 93. Latin America General Anesthesia Drugs Market (US$ Mn), by Sevoflurane, 2020-2034
  - Figure 94. Latin America General Anesthesia Drugs Market (US$ Mn), by Dexmedetomidine, 2020-2034
  - Figure 95. Latin America General Anesthesia Drugs Market (US$ Mn), by Remifentanil, 2020-2034
  - Figure 96. Latin America General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 97. Latin America General Anesthesia Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 98. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - Figure 99. Latin America General Anesthesia Drugs Market (US$ Mn), by Intravenous, 2020-2034
  - Figure 100. Latin America General Anesthesia Drugs Market (US$ Mn), by Inhaled, 2020-2034
  - Figure 101. Latin America General Anesthesia Drugs Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 102. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - Figure 103. Latin America General Anesthesia Drugs Market (US$ Mn), by Heart Surgeries, 2020-2034
  - Figure 104. Latin America General Anesthesia Drugs Market (US$ Mn), by Knee & Hip Replacements, 2020-2034
  - Figure 105. Latin America General Anesthesia Drugs Market (US$ Mn), by General Surgery, 2020-2034
  - Figure 106. Latin America General Anesthesia Drugs Market (US$ Mn), by Cancer, 2020-2034
  - Figure 107. Latin America General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 108. Latin America General Anesthesia Drugs Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 109. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - Figure 110. Latin America General Anesthesia Drugs Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 111. Latin America General Anesthesia Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2020-2034
  - Figure 112. Latin America General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 113. Latin America General Anesthesia Drugs Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 114. Latin America General Anesthesia Drugs Market Attractiveness Analysis, By Country
  - Figure 115. Middle East & Africa General Anesthesia Drugs Market Analysis, By Drug, 2020, 2024 and 2034
  - Figure 116. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By Drug
  - Figure 117. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Propofol, 2020-2034
  - Figure 118. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Sevoflurane, 2020-2034
  - Figure 119. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Dexmedetomidine, 2020-2034
  - Figure 120. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Remifentanil, 2020-2034
  - Figure 121. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 122. Middle East & Africa General Anesthesia Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 123. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By Route of Administration
  - Figure 124. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Intravenous, 2020-2034
  - Figure 125. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Inhaled, 2020-2034
  - Figure 126. Middle East & Africa General Anesthesia Drugs Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 127. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By Application
  - Figure 128. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Heart Surgeries, 2020-2034
  - Figure 129. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Knee & Hip Replacements, 2020-2034
  - Figure 130. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by General Surgery, 2020-2034
  - Figure 131. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Cancer, 2020-2034
  - Figure 132. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 133. Middle East & Africa General Anesthesia Drugs Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 134. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By End-user
  - Figure 135. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 136. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Ambulatory Surgical Centers, 2020-2034
  - Figure 137. Middle East & Africa General Anesthesia Drugs Market (US$ Mn), by Others, 2020-2034
  - Figure 138. Middle East & Africa General Anesthesia Drugs Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 139. Middle East & Africa General Anesthesia Drugs Market Attractiveness Analysis, By Country
- Pfizer
- Hikama Pharmaceuticals plc
- Eugia Steriles
- Baxter International
- Braun Melsungen AG
- AstraZeneca
- Amneal Pharmaceuticals
- Abbott Laboratories